Quoin Pharmaceuticals Q4 EPS $(0.41) Beats $(0.62) Estimate
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.62) by 33.87 percent.
Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell
• Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Dow Rises 50 Points; Quoin Pharmaceuticals Shares Plunge
U.S. stocks traded slightly higher toward the end of trading following the release of Fed minutes.
The Dow traded up 0.15% to 33,180.87 while the NASDAQ rose 0.49% to 11,548.73. The S&P 500 also rose, gaining, 0.33% to 4,010.53.
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure."
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Windtree Therapeutics (NASDAQ:WINT) stock moved upwards by 63.5% to $0.28 during Wednesday’s regular session. The current volume…
Why Quoin Pharmaceuticals Shares Are Getting Obliterated Wednesday
Quoin Pharmaceuticals Ltd - ADR (NASDAQ: QNRX) shares are trading lower by 42.82% to $0.68 Wednesday morning. The company announced pricing of its $7 million public offering.
What Else?
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket
Gainers
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
Gainers
Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
Crude Oil Drops Over 2%; Akouos Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 300 points on Tuesday.